Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Size Changed, over the years?
The market size of the rapid test based on lateral flow immunoassay (LFIA) has experienced a sharp drop in recent years. The contraction escalated from $8.03 billion in 2024 to $7.23 billion in 2025, demonstrating a compound annual growth rate (CAGR) of -9.9%. Factors such as restricted sensitivity and specificity, the complexity of multiplexing, cross-reactivity problems, storage and shelf-life concerns, and limited quantitative ability contributed to the decline during the historical period.
How Much Will the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Be Worth in 2029?
Expectations depict a steady rise in the market size of the lateral flow immunoassay (LFIA) based rapid test in the upcoming years, achieving $8.3 billion in 2029 with a compound annual growth rate (CAGR) of 3.5%. This downfall in the forecast period can be ascribed to disruptions in the global supply chain, regulatory obstacles, heightened competition, the rise of alternative technologies, and incorporation with digital health platforms. Future trends in the forecast period may include the development of advanced technologies for multiple or repetitive LFIA based rapid tests and result storage/communication, emphasis on partnerships and collaborations, home testing kit development, investments in AI-based tests for disease screening and detection, as well as the development of affordable testing kits for easy and low-cost patient accessibility.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3293&type=smp
Which is the Largest Company in the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market?
Major companies operating in the lateral flow immunoassay (LFIA) based rapid test market include Abbott Laboratories, F. Hoffmann-La Roche, Quidel Corporation, Becton, Dickinson and Company, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hologic, Inc., LTEK Co., Ltd., JOYSBIO Biotechnology, Jiangsu Medomics Medical Technologies, Diagnocure, Ubio Biotechnology Systems, Elabscience® Immunoassay Kits, FyoniBio / Glycotope GmbH, Atomo Diagnostics Limited, INDICAL Bioscience, Lionex Gmbh, BIOMED Labordiagnostik GmbH, Charles River Laboratories, EKF Diagnostics, Launch Diagnostics, Diagnostic Instruments Ltd, Qiagen N.V., Merck KGaA, XPhyto Therapeutics, 3a Diagnostics, Roche Holding AG, BATM, Biomaxima, SensDx, Vitrosens Biotechnology, Bioeasy Biotechnology, Fujirebio, Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, CTK Biotech
What Are the Main Market Drivers in the Lateral Flow Immunoassay (LFIA) Based Rapid Test Industry?
The persistent problem of quality control is anticipated to impede the expansion of the lateral flow immunoassay (LFIA) based rapid test market. Rising operational expenses, encompassing salaries and investments in technology, are putting strain on the profit margins of numerous law firms. For example, PLOS, a non-profit organization based in the United States, stated in June 2023 that LFIA products available on the market do not regularly fulfill their high reliability and specificity standards. When looking back at four LFIA tests, it was revealed that their diagnostic performance was incredibly varied, with some tests only demonstrating a scant 47% accuracy level for IgG detection.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=3293&type=smp
How Is the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Segments Structured?
The lateral flow immunoassay (LFIA) based rapid test market covered in this report is segmented –
1) By Technique: Competitive Assay, Sandwich Assay, Multiplex Detection Assay
2) By Application: Infectious Disease, Pregnancy And Fertility, Toxicology, Cardiac Marker And Cholesterol Testing, Other Applications
3) By End-Users: Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End Users
Subsegments:
1) By Competitive Assay: Direct Competitive Assays, Indirect Competitive Assays
2) By Sandwich Assay: Single-step Sandwich Assays, Two-step Sandwich Assays
3) By Multiplex Detection Assay: Multi-analyte Assays, Simultaneous Detection Of Various Targets
What Strategic Trends Are Transforming the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market?
Key players in the lateral flow immunoassay (LFIA)-based rapid test market are concentrating on innovative technologies like qPCR technology to improve the accuracy and specificity of their tests, increase their detection speed, and broaden the spectrum of pathogens or biomarkers that can be detected. This would ultimately result in more reliable diagnostic solutions for a range of healthcare uses. The qPCR (quantitative polymerase chain reaction) technique, a molecular biology method, is utilized to intensify and measure DNA or RNA sequences in real-time. It affords exact measurement of gene expression levels or the identification of specific pathogens in various samples. To illustrate, F. Hoffmann-La Roche AG, a pharmaceutical company based in Switzerland, introduced the LightCycler PRO System in November 2023. The LightCycler PRO expands on Roche’s track record of qPCR systems, employing top-tier technology for high-grade quality, precision, and reliability. These qualities are vital for accurate patient diagnosis and the creation of effective clinical decisions.
Access The Full Report Here:
Which Global Regions Offer the Highest Growth in the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market?
North America was the largest region in the lateral flow immunoassay (LFIA) based rapid test market in 2024. Asia-Pacific was the second largest region in the global lateral flow immunoassay (LFIA) based rapid test market. The regions covered in the lateral flow immunoassay (LFIA) based rapid test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3293
This Report Delivers Insight On:
1. How big is the lateral flow immunoassay (lfia) based rapid test market, and how is it changing globally?
2. Who are the major companies in the lateral flow immunoassay (lfia) based rapid test market, and how are they performing?
3. What are the key opportunities and risks in the lateral flow immunoassay (lfia) based rapid test market right now?
4. Which products or customer segments are growing the most in the lateral flow immunoassay (lfia) based rapid test market?
5. What factors are helping or slowing down the growth of the lateral flow immunoassay (lfia) based rapid test market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
